HCA Healthcare, Inc. $HCA Holdings Decreased by ProShare Advisors LLC

ProShare Advisors LLC lowered its stake in HCA Healthcare, Inc. (NYSE:HCA) by 8.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 23,800 shares of the company’s stock after selling 2,338 shares during the quarter. ProShare Advisors LLC’s holdings in HCA Healthcare were worth $10,156,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. SBI Securities Co. Ltd. increased its position in shares of HCA Healthcare by 24.7% during the 3rd quarter. SBI Securities Co. Ltd. now owns 111 shares of the company’s stock worth $47,000 after purchasing an additional 22 shares during the last quarter. Beacon Capital Management LLC boosted its holdings in shares of HCA Healthcare by 0.7% in the 3rd quarter. Beacon Capital Management LLC now owns 3,631 shares of the company’s stock valued at $1,550,000 after buying an additional 25 shares during the last quarter. Diversify Advisory Services LLC grew its stake in shares of HCA Healthcare by 3.3% in the third quarter. Diversify Advisory Services LLC now owns 806 shares of the company’s stock valued at $378,000 after buying an additional 26 shares in the last quarter. AdvisorNet Financial Inc increased its holdings in HCA Healthcare by 3.5% during the third quarter. AdvisorNet Financial Inc now owns 994 shares of the company’s stock worth $468,000 after buying an additional 34 shares during the last quarter. Finally, Integrated Advisors Network LLC increased its holdings in HCA Healthcare by 0.6% during the third quarter. Integrated Advisors Network LLC now owns 5,469 shares of the company’s stock worth $2,334,000 after buying an additional 35 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have commented on HCA shares. Bank of America increased their price target on shares of HCA Healthcare from $450.00 to $500.00 and gave the company a “neutral” rating in a research note on Wednesday, October 28th. Barclays boosted their price objective on shares of HCA Healthcare from $387.00 to $401.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 29th. BMO Capital Markets began coverage on shares of HCA Healthcare in a report on Tuesday, September 22nd. They issued an “outperform” rating and a $495.00 target price on the stock. Wall Street Zen upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, KeyCorp boosted their price target on HCA Healthcare from $435.00 to $490.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 28th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $480.13.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Truist reaffirmed its “Buy” rating and raised its price target to $510 from $495, suggesting confidence in HCA’s prospects. Read More.
• Positive Sentiment: HCA plans a $300 million hospital in Cape Coral, Florida, with $31 million in city incentives. The project could support future capacity and growth, though it also entails significant investment. Cape Coral hospital article
• Neutral Sentiment: An HCA subsidiary plans to issue senior notes. The financing may support corporate needs, but the available report does not provide terms or indicate how much debt will be added. Senior notes offering
• Negative Sentiment: A report on HCA’s third-quarter payer mix highlights an estimated $400 million cost burden associated with a shift toward uninsured patients. Higher uncompensated-care costs could weigh on margins. Q3 revenue by payer article
• Negative Sentiment: Pomerantz LLP said it is investigating potential claims on behalf of HCA investors. An investigation is not a finding of wrongdoing, but the announcement adds legal and reputational uncertainty. Investor investigation announcement
• Negative Sentiment: A reported data breach affected about 55,000 people, creating potential privacy, remediation and reputational risks. Data breach report

HCA Healthcare Price Performance

Shares of HCA opened at $462.52 on Wednesday. The firm has a market capitalization of $96.62 billion, a PE ratio of 15.33, a PEG ratio of 1.56 and a beta of 1.11. The company’s 50-day moving average is $438.88 and its 200-day moving average is $444.76. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, topping the consensus estimate of $6.65 by $0.57. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The business had revenue of $19.85 billion during the quarter, compared to the consensus estimate of $19.33 billion. During the same quarter in the previous year, the firm posted $6.96 EPS. HCA Healthcare’s revenue was up 3.6% compared to the same quarter last year. Analysts predict that HCA Healthcare, Inc. will post 30.15 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 29th. Stockholders of record on Tuesday, December 15th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, December 15th. HCA Healthcare’s payout ratio is currently 10.34%.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.